Weight loss plateaus are common, but in many cases, the reasons are identifiable and fixable, say doctors. ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

WEIGHT loss jabs have been a godsend for people in the UK living with obesity. But despite 1.5 million people using the weight loss medication in a single month, many users say they haven’t ...

Mounjaro, originally a diabetes drug, aids significant weight loss by curbing appetite and improving insulin sensitivity. Weekly injections offer sustained results but come with potential side effects ...

Mounjaro was approved by the FDA in May, becoming the first combined GLP-1/GIP agonist to reach the market, ... and data on titration rates and patients stopping or not adhering to therapy, ...

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials.